Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FYSIOFILM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.7% 17.4% 12.8% 16.5% 10.5% 7.1% 20.1% 20.1%   Credit score (0-100)   19 9 17 10 22 34 6 6   Credit rating   BB B BB BB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   40.4 -33.9 24.2 249 163 199 0.0 0.0   EBITDA   40.4 -33.9 24.2 168 47.0 84.8 0.0 0.0   EBIT   15.7 -35.9 24.2 168 47.0 84.8 0.0 0.0   Pre-tax profit (PTP)   15.6 -36.8 23.2 166.6 47.0 86.3 0.0 0.0   Net earnings   12.1 -28.7 17.9 141.1 34.7 65.9 0.0 0.0   Pre-tax profit without non-rec. items   15.6 -36.8 23.2 167 47.0 86.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   89.8 61.1 79.0 220 255 321 86.4 86.4   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   203 95.2 130 438 488 642 86.4 86.4   Net Debt   -89.3 -53.9 -110 -166 -200 -293 -86.4 -86.4     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   40.4 -33.9 24.2 249 163 199 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 926.9% -34.4% 21.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   203 95 130 438 488 642 86 86   Balance sheet change%   -8.0% -53.2% 36.7% 236.6% 11.4% 31.6% -86.5% 0.0%   Added value   40.4 -33.9 24.2 167.6 47.0 84.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -49 -4 0 185 0 0 -185 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   38.9% 106.1% 100.0% 67.3% 28.8% 42.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.4% -24.1% 21.5% 59.0% 10.3% 15.3% 0.0% 0.0%   ROI %   18.5% -47.5% 34.6% 108.4% 19.3% 29.0% 0.0% 0.0%   ROE %   14.4% -38.1% 25.6% 94.4% 14.6% 22.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   72.7% 64.1% 60.7% 50.3% 52.2% 50.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -221.1% 159.1% -453.8% -99.0% -424.9% -345.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   6.1 2.8 2.5 1.2 1.4 1.5 0.0 0.0   Current Ratio   1.8 2.8 2.5 1.2 1.4 1.5 0.0 0.0   Cash and cash equivalent   89.3 53.9 110.0 166.0 199.9 293.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   88.2 61.1 79.0 45.3 80.2 145.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   40 -34 24 168 47 85 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   40 -34 24 168 47 85 0 0   EBIT / employee   16 -36 24 168 47 85 0 0   Net earnings / employee   12 -29 18 141 35 66 0 0